Mycro-3
Mycro3 is a small-molecule inhibitor of Myc-Max dimerization. The average residual tumor of Pdx1-cre/KRAS* mice after Mycro3 treatment (100mg/kg, orally, daily for 2 months) is approximately 30%.
| Trivial name | / |
| Catalog Number | CSN25655 |
| Alternative Name(s) | / |
| Research Area | Cancer |
| Molecular Formula | C24H17ClF2N6O4 |
| CAS# | 944547-46-0 |
| Purity | ≥98% |
| SMILES | CCOC(=O)C1=C(NC(=O)C2=NN3C(=C2)N=C(C=C3C(F)(F)Cl)C2=CC=CO2)N(N=C1)C1=CC=CC=C1 |
| Size | 50mg |
| Supplier Page | https://www.csnpharm.com/products/mycro-3.html |